GWW vs STOK · P/E 27, rev $9.76B vs rev $15.6M
WW Grainger Inc (GWW) versus Stoke Therapeutics Inc (STOK) — a side-by-side from cached financials, not a winner call.
WW Grainger Inc (GWW) is a industrial distribution company listed on US.
Stoke Therapeutics Inc (STOK) is a biotechnology company listed on NASDAQ.
Latest reported GWW revenue for 2026-06-30 was $9.76B. Net income was $1.13B. GWW currently screens at market cap $50.34B and trailing P/E 26.9.
Latest reported STOK revenue for 2026-06-30 was $15.6M. Net income was -$111.6M. STOK currently screens at market cap $1.88B.
GWW currently screens at market cap $50.34B and trailing P/E 26.9. STOK currently screens at market cap $1.88B.
Not investment advice. Open the GWW and STOK stock pages for the full models.
Not investment advice.